Last reviewed · How we verify

NCT03823612

Reminerlization Potential of Innovative Biomimetic Material in Caries White Spot Lesions

Status unknown Phase 4 Last updated 30 January 2019
What this trial tests

Phase 4 trial testing Clinpro Tooth Creme in White Spot Lesion of Tooth in 34 participants. Status unknown.

Timeline
1 March 2019
Primary endpoint
1 September 2019
1 October 2019

Quick facts

Lead sponsorCairo University
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment34
Start date1 March 2019
Primary completion1 September 2019
Estimated completion1 October 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 40, any sex, with White Spot Lesion of Tooth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

to remineralize the white spot caries lesions after orthodontic treatment , the investigator will use two different materials ( Clinpro tooth creme versus Gc tooth mousse) and will compare between their effects in remineralization of white spot caries lesions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for White Spot Lesion of Tooth

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03823612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing